The QualityStocks Daily Stock List
- Coastal Carolina Bancshares, Inc. (CCNB)
- DATATRAK International, Inc. (DTRK)
- Frelii, Inc. (FRLI)
- Notox Technologies Corp. (NTOX)
- Pacific Health Care Organization, Inc. (PFHO)
- Simplicity Esports and Gaming Company (WINR)
- Teranga Gold Corporation (TGCDF)
- Kiwa Bio-Tech Products Group Corporation (KWBT)
- EPHS Holdings, Inc. (STNN)
- Black Cactus Global, Inc. (BLGI)
- Lexington Biosciences, Inc. (LXGTF)
- Towerstream Corp. (TWER)
- Sustainable Projects Group, Inc. (SPGX)
- Bravo Multinational, Inc. (BRVO)
Coastal Carolina Bancshares, Inc. (CCNB)
Financial Content, StockScores, PR Newswire, Stockopedia, Wallet Investor, TradingView, Stockhouse, Dividend Investor, Wallmine, and Stockwatch reported earlier on Coastal Carolina Bancshares, Inc. (CCNB), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Coastal Carolina Bancshares, Inc. operates as a holding company for Coastal Carolina National Bank. The Bank provides varied banking products and services in Myrtle Beach, South Carolina. It serves individuals, businesses, and small-medium sized commercial, professional, and service companies. Incorporated in 2008, Coastal Carolina Bancshares has its headquarters in Myrtle Beach and the Company lists on the OTCQX.
The community Bank serves Horry, Georgetown, Aiken, Richland, Lexington, Greenville (SC), and Brunswick (NC) counties. Coastal Carolina National Bank (CCNB) provides a complete range of deposit and lending services for small business customers and individuals. Furthermore, the Bank offers full-service residential mortgage lending capabilities consisting of residential first and second mortgage loans and construction loans.
Concerning Personal Banking, CCNB offers Checking Account options; Savings Accounts; Personal Loans including Home Equity Lines of Credit; and Personal Credit Cards. For Business, it offers Checking options including Business Advantage Checking and Commercial Advantage Checking. In addition, the Bank offers Commercial Loans; and Savings options, such as Premier Commercial Money Market, Commercial Money Market, and Certificates of Deposit. Moreover, it provides a complete line of services to meet a business’s needs. Additionally, the Bank offers CCNB Business Credit Cards.
CCNB also offers a variety of mortgage options. These include Conventional Mortgages, Jumbo Mortgages/Adjustable Rate Loans, and Low-Down-Payment loans: FHA, VA Loans, USDA Loans. Also, the Bank offers Construction/Permanent Loans, Condotel Loans, Portfolio Loans, Bridge Loans/Short-term financing, Lot Loans, as well as Refinancing.
This past July, CCNB announced Net Income of $1,125,445 or $.18 cents per diluted share for the six months ended June 30, 2019 versus $920,402 for the same period the year prior.
Mr. Laurence S. Bolchoz, Jr., President and Chief Executive Officer of the Company and the Bank, said, “We are very pleased with our strong financial performance in the second quarter of 2019. We experienced dramatic asset and deposit growth of $36 million by continuing our focus on establishing quality retail and commercial deposit relationships in all of our markets. Our deposit growth for the quarter was bolstered by a large temporary deposit of approximately $8 million on the last day of the quarter. Excluding this temporary deposit, we still had $28 million in deposit and asset growth figures for the quarter, which is quite significant.”
Coastal Carolina Bancshares, Inc. (CCNB), closed Friday's trading session at $8.00, even for the day, on 1,145 volume with 4 trades. The average volume for the last 3 months is 1,523 and the stock's 52-week low/high is $6.38181877/$8.40909194.
DATATRAK International, Inc. (DTRK)
Zacks, Investor Village, PR Newswire, OTC Markets, InvestorsHub, stock2own, Infront Analytics, Wallmine, Investors Hangout, Wallet Investor, Whale Wisdom, Capital Cube, Stockwatch, MarketBeat, and Last10k reported previously on DATATRAK International, Inc. (DTRK), and today we report on the Company, here at the QualityStocks Daily Newsletter.
DATATRAK International, Inc. provides unified eClinical solutions and related services for the clinical trials industry. A technology and services company, it is an international Software-as-a-Service (SaaS) provider and innovation leader of cloud-based technologies for the life sciences industry. DATATRAK International is based in Mayfield Heights, Ohio. Formed in 1991, the Company lists on the OTC Markets.
DATATRAK delivers a complete portfolio of software products. The design of these to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities more efficiently than loosely integrated technologies. The Company’s vision is to continue to build and own a multilingual and multi-tenant enterprise platform with unified access to clinical applications, database and workflows.
The Datatrak Enterprise Cloud supports Pre-clinical and Phase I - Phase IV drug and device studies in numerous languages around the world. The Datatrak Enterprise Cloud includes manifold products. These include Clinical Trial Management System (CTMS), Trial Design, Electronic Data Capture (EDC), Medical Coding, Risk Based Monitoring, ECG Data Capture, Image Data Capture, Endpoint Adjudication, Randomization, Clinical Supply Inventory, eConsent, ePRO and Business Analytics.
DATATRAK’s commitment is to empowering workgroup teams with role-based access to version-controlled file management, calendar events, tasks and contacts, all built within their eClinical applications. These include EDC, CTMS, reporting, data analytics, and business intelligence.
This week, DATATRAK International announced that NTT Data has extended and expanded its relationship with DATATRAK for an additional 5 years, through 2024.
Mr. Jim Bob Ward, Chief Executive Officer and President of DATATRAK International, said, "Under the terms of the agreement, NTT Data will expand its sales and support beyond EDC to include the larger Datatrak Enterprise Cloud for Japan and the growing Asia-Pacific market. We are excited to build upon a 10-year partnership with NTT by offering cloud-based Business Intelligence, Clinical Trial Management (CTMS), Electronic Data Capture (EDC), lab image capture and Endpoint Adjudication (EAS), patient data capture from smartphones and tablets (ePRO), and wearable Bluetooth devices (eCOA), all with informed consent (eConsent) through multiple languages."
For Q2 2019, DATATRAK attained its fifth consecutive quarter of profitability. The Company also saw an increase in backlog during the six months ended June 30, 2019. Revenue for Q2 of 2019 was $1,884,000 versus $1,931,000 for Q2 of 2018. Revenue grew for the six months ended June 30, 2019 by $120,000, to $3,806,000 versus $3,686,000 for the six months ended June 30, 2018.
The Company had Income from Operations for the three months ended June 30, 2019 of $28,000 versus $159,000 for the three months ended June 30, 2018. DATATRAK had Income from Operations of $193,000 and $48,000 for the six months ended June 30, 2019 and 2018, respectively.
DATATRAK International, Inc. (DTRK), closed Friday's trading session at $6.00, even for the day, on 55 volume. The average volume for the last 3 months is 737 and the stock's 52-week low/high is $2.30999994/$8.00.
Frélii, Inc. (FRLI)
Market Screener, Business Wire, The Health Investor, Wallet Investor, Investing Online, Seeking Alpha, MarketWatch, DNA Investor Alerts, Trade Ideas, Simply Wall St, Last10k, Investors Hangout, and Northfield Review reported previously on Frélii, Inc. (FRLI), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Frélii, Inc. is a medical technology company listed on the OTC Markets. It uses gene sequencing and artificial intelligence (AI) to determine risk and lifestyle modifications. Its technology analyzes the most comprehensive markers (60,000,000-plus) on the market to date. The Company previously went by the name Vican Resources, Inc. It changed its corporate name to Frélii, Inc. in March 2018. The Company is headquartered in Lehi, Utah.
Frélii’s technology generates accurate and very valuable insight into DNA. Frélii says that it opens opportunities never realized in health care, precision medicine, insurance, corporate wellness and personal health and risk identification. In essence, the Company is data mining DNA. It leverages the big data of DNA to improve health and wellness and enhance the human experience. The design of the Company’s technology has been to allow assessment and sequencing, for reporting needs into diverse life science environments.
Frélii takes a unique approach to health through taking advantage of its highly advanced AI to deliver more holistic DNA analysis. This is to provide precision regarding what medical professionals and individuals need concerning correct drugs, dosing, diet and interventions. The Company continues to develop and grow its patented AI technology, leveraged base code and large data sets gathered from public and private partnerships.
Frélii’s predictive capacity with its precision medicine and health and wellness AI has rose from 84 percent to 98.5 percent. Additionally, the flagship high-efficiency Genetic Sequencing and analysis using the Company’s proprietary technology has increased to more than 99 percent and 99.999 percent accuracy on whole genome and exome sequencing, respectively.
This past June, Frélii announced the details of its earlier agreement with Orn Health, Inc., a medical services provider, to license the Frélii exome and whole genome sequencing and AI technology for use with new franchisee partners in their own medical practices for enhancing patient treatment resources. At present, Frelii provides a consumer-level DNA Kit Package™ and report with alignment specifically for OTC cannabis, CBD (cannabidiol), supplements and nutraceuticals, which can be disseminated directly to a consumer without the presence of a physician or licensed healthcare provider.
The Company has forged this partnership with Orn Health to create broader opportunities for Frélii within the medical and healthcare industries, specifically. Orn Health (Farmington, Utah) serves as a primary care facility and headquarters for Orn.
Frélii, Inc. (FRLI), closed Friday's trading session at $0.1599, up 14.2143%, on 57,616 volume with 20 trades. The average volume for the last 3 months is 104,074 and the stock's 52-week low/high is $0.120999999/$3.00.
Notox Technologies Corp. (NTOX)
Penny Stock Hub, Market Exclusive, Stockopedia, Investors Hangout, Last10k, Stock Target Advisor, PredictWallStreet, Wallstreet Online, Wallet Investor, Market Screener, Stockwatch, Simply Wall St, TradingView, and Stockhouse reported earlier on Notox Technologies Corp. (NTOX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed, Notox Technologies Corp. centers on developing and commercializing unique technologies. It is doing so chiefly through its wholly-owned Nevada subsidiary Notox Bioscience, Inc. The Company is working to market a credible, non-toxic alternative to Botox and subsequently develop other features of its Notox technology. This includes drug-free pain management, body countering, skin tightening, as well as anti-perspiration. A Nevada corporation, Notox Technologies is based in Richmond Hill, Ontario.
Notox Technologies is also is working to build its distribution capabilities for other medical and aesthetic products globally. In February of this year, it announced that it entered into a relationship with the Veterans Global Initiative Foundation. This relationship is to raise capital for the testing, development, and commercialization of Notox’s drug-free pain management solutions, primarily for the benefit of military veterans who suffer from pain. Notox Technologies and the VGI Foundation are working together to provide the Notox treatment either at no cost or at deeply discounted rates to those veterans who need relief the most and continue to suffer in cases where other treatments have not worked.
Notox Technologies has transitioned over the past two years into developing, commercializing, and promoting its patented Notox aesthetic and drug-free pain management platform. This is following its acquisition of the associated intellectual property (IP) rights in 2016. That patented IP was originally developed by Dr. Frank Papay, MD FACS Chairman Dermatology and Plastic Surgery Institute, Cleveland Clinic, and is owned by The Cleveland Clinic Foundation.
Notox Technologies announced this past July that it entered into a binding Letter Of Intent (LOI) with Xthetica, Inc. to acquire certain of Xthetica's assets in consideration for the issuance of shares and warrants of Notox Technologies to the sole shareholder of Xthetica, Mr. Manny Kapur. Those assets include Xthetica's rights and obligations under a series of distribution agreements with manufacturers of aesthetic and medical beauty products, access to all of Xthetica's current inventory, and the goodwill of Xthetica. Xthetica is a private Canadian aesthetic and medical beauty distributor.
At present, Xthetica services a large number of clinics in the Canadian marketplace. Via this acquisition, Notox is expected to gain direct access to over 200 of those clinics along with the right to distribute an array of products and services now controlled by Xthetica. With the fast growth of the beauty world market, Xthetica is ready to provide suitable conditions to successfully address significant economic opportunities in the field of minimally invasive aesthetic dermatology.
Notox Technologies Corp. (NTOX), closed Friday's trading session at $4.50, even for the day, on 25 volume. The average volume for the last 3 months is 6 and the stock's 52-week low/high is $1.98000001/$4.50.
Pacific Health Care Organization, Inc. (PFHO)
NetworkNewsWire, Zacks, TeleTrader, 4-Traders, GlobeNewswire, Simply Wall St, Wallet Investor, Stockopedia, InvestorsHub, Investors Hangout, Capital Cube, GuruFocus, Last10k, Infront Analytics, Dividata, Journal Transcript, Whale Wisdom, Market Exclusive, Open Insider, Trading View, Dividend Investor, Research Pool, Market Screener, Stockhouse, and MarketBeat reported previously on Pacific Health Care Organization, Inc. (PFHO), and we also report on the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed, Pacific Health Care Organization, Inc. specializes in workers’ compensation cost containment. The Company’s business objective is to deliver value to its clients that lessens their workers’ compensation related medical claims expense in a way that will assure that injured employees receive high quality healthcare that allows them to recover from injury and return to gainful employment without unnecessary delay. Incorporated in 1970, Pacific Health Care Organization is based in Newport Beach, California.
Pacific Health Care Organization’s subsidiaries include Medex Healthcare, Medex Managed Care, Medex Medical Management, Medex Legal Support, and IRC (Industrial Resolutions Coalition). Through its two HCOs, the Company offers injured workers a choice of enrolling in an HCO with a network managed by primary care providers requiring a referral to specialists; or a second HCO, where injured workers do not need any prior authorization to be seen and treated by specialists.
Via its wholly-owned subsidiaries, Pacific Health Care Organization provides a range of effective workers’ compensation cost containment services. These include, but are not limited to, Health Care Organizations, Medical Provider Networks, HCO + MPN, Workers’ Compensation Carve-Outs, Utilization Review, Medical Bill Review, Nurse Case Management, Lien Representation, Legal Support and Medicare Set-Aside services.
Last month, Pacific Health Care Organization reported its Q2 2019 results. Total Revenues for Q2 2019 were $1,815,319 versus $1,661,517 for the same period in 2018. This represents an increase of $153,802 or 9 percent. For the first six months of 2019 it recorded Total Revenue of $3,598,757 versus Total Revenues of $3,244,826 for the same period in 2018. This represents an increase of $353,931 or 11 percent.
Pacific Health Care Organization reported Net Income of $248,704, or $0.08 per basic and fully diluted common share for Q2 ended June 30, 2019, versus Net Income of $325,154, or $0.10 per basic and fully diluted common share for Q2 ended June 30, 2018. For the first six months of 2019, the Company reported Net Income of $563,267 or $0.18 per basic and fully diluted common share, versus Net Income of $724,835 or $0.23 per basic and fully diluted common share for the first six months of 2018.
Pacific Health Care Organization, Inc. (PFHO), closed Friday's trading session at $4.60, even for the day, on 16 volume. The average volume for the last 3 months is 112 and the stock's 52-week low/high is $2.75/$5.90000009.
Simplicity Esports and Gaming Company (WINR)
Penny Stock Base, GlobeNewswire, Investor Ideas, Market Screener, MarketWatch, and TeleTrader reported beforehand on Simplicity Esports and Gaming Company (WINR), and we also report on the Company, here at the QualityStocks Daily Newsletter.
Simplicity Esports and Gaming Company is an established brand in the esports industry. The Company has an engaged fan base competing in popular games across diverse genres. These include PUBG, Fortnite, League of Legends, Overwatch, Gears of War, Smite, and numerous EA Sports titles. Simplicity Esports and Gaming’s shares trade on the OTC Markets Group’s OTCQB. The Company formerly went by the name Smaaash Entertainment, Inc. It changed its corporate name to Simplicity Esports and Gaming Company in January 2019. Incorporated in 2017, Simplicity Esports and Gaming is based in New York City.
The Company is an international virtual reality gaming and fully integrated eSports platform business. It is an emerging operator and developer of family entertainment centers across the United States, combining proprietary sports, eSports, virtual and augmented reality gaming as well as dining into a highly interactive and innovative social experience for family and friends. Simplicity’s fully integrated eSports platform concept will include the development of dedicated eSports centers nationwide beginning this year, alongside the management of eSports teams at all competitive levels.
The grand opening of Simplicity Esports and Gaming’s first Esports Center in Boca Raton, Florida took place Saturday, May 4, 2019. The Boca Raton Esports Center is branded and decorated with high tech RGB LED décor and sophisticated gaming gear. Customers can game on over 30 different high performance gaming stations including PC’s and consoles covering more than 50 well known titles across popular gaming genres. The Boca Raton Center includes a private room for streaming, boot camps, and also tournament commentary.
Simplicity Esports and Gaming’s second Esports Center is in DeLand, Florida. This location provides customers greater than 40 high-performance gaming stations. These including PCs and consoles. This facility will fully integrate with Simplicity Esports’ Boca Raton location.
At the end of July, Simplicity Esports and Gaming announced that it closed the earlier announced acquisition of PLAYlive Nation, Inc. PLAYlive has a network of 44 franchised Gaming Centers throughout 11 States, including but not limited to, California, Washington, Arizona, and Texas, serving more than 150,000 unique gamers per year. PLAYlive Centers are highly complementary to Simplicity Esports Gaming Centers, which offer gamers a specialized entertainment gaming experience within a social setting.
This week, Simplicity Esports and Gaming announced that it expects to have 85 esports gaming centers by the end of 2020.
Simplicity Esports and Gaming Company (WINR), closed Friday's trading session at $2.31, off by 5.9063%, on 4,173 volume with 14 trades. The average volume for the last 3 months is 3,712 and the stock's 52-week low/high is $0.560000002/$11.0500001.
Teranga Gold Corporation (TGCDF)
Street Insider, TipRanks, 24hourgold, Stockhouse, InvestorsHub, Mining Stock Valuator, Invest Tribune, Wallet Investor, Market Screener, and Dividend Investor reported previously on Teranga Gold Corporation (TGCDF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Teranga Gold Corporation engages in the exploration, development, production, and sale of gold in West Africa. It is a multi-jurisdictional West African gold company also focused on the exploration of about 6,400 km2 of land positioned on prospective gold belts. The Company’s projects include Sabodala, Wahgnion, and Golden Hill. Teranga Gold is headquartered in Toronto, Ontario and the Company’s shares trade on the OTC Markets Group’s OTCQX.
The Sabodala gold mine is situated in the Republic of Senegal. The Wahgnion gold project is located in Burkina Faso. The 100 percent owned Golden Hill project is positioned in southwestern Burkina Faso on the Houndé belt. Golden Hill includes three exploration permits covering an area of around 468 square kilometers. Furthermore, Teranga Gold develops and explores various projects in Burkina Faso, Côte d'Ivoire, and Senegal.
At the beginning of August, Teranga Gold reported financial, operating, and development results for the three and six months ended June 30, 2019. Q2 gold production was 63,436 ounces, 3 percent lower than last year’s record Q2. Cost of sales per ounce was $1,016. This represents an increase of 12 percent primarily because of higher mine operation expenses, depreciation and amortization expenses, as well as lower gold ounces sold.
At Wahgnion, construction continued to progress well during the quarter. First gold pour remains on schedule and ahead of the National Instrument 43-101 Standards of Disclosure for Mineral Projects (NI 43-101) technical report initially released on October 31, 2018.
At Golden Hill, Teranga Gold’s most advanced exploration project in Burkina Faso, an initial early-stage mineral resource estimate for the project’s most advanced prospects was announced on February 21, 2019. Teranga has initiated a 27,000-meter drill program designed to boost the resource base and started initial studies and test work related to producing a technical report to support the application for a mine license in 2020.
Mr. Richard Young, President & Chief Executive Officer, said, “Operationally, Sabodala reported a solid second quarter. Wahgnion remains well on schedule and we have begun commissioning and expect production to ramp up in the fourth quarter. With Sabodala delivering significant cash flow and Wahgnion in commissioning, we are investing in the next stage of our organic growth pipeline.” This month, Teranga Gold announced that its second mine, Wahgnion Gold Operations, commenced processing ore during August. Wahgnion, situated in the southwest portion of Burkina Faso, West Africa, is expected to produce 30,000 to 40,000 ounces of gold this year.
Teranga Gold Corporation (TGCDF), closed Friday's trading session at $3.90764, off by 3.7527%, on 12,813 volume with 53 trades. The average volume for the last 3 months is 29,593 and the stock's 52-week low/high is $2.2262001/$4.36000013.
Kiwa Bio-Tech Products Group Corporation (KWBT)
Lions of Wall Street, Fast Moving Stocks, Darth Trader, Wallstreetlivechat, OTC Picks, Penny Stock Rumble, StockMister, The Penny Play, Equities, SmallCapVoice, The Stock Psycho, and Top Gun reported previously on Kiwa Bio-Tech Products Group Corporation (KWBT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Kiwa Bio-Tech Products Group Corporation is a manufacturer concentrating on eco-friendly bio-based fertilizers promoting soil health. The Company develops, manufactures, distributes, and markets novel, cost-effective and environmentally safe bio-technological products for agricultural and environmental conservation. Organic, ecologically sound, and "green" practices are its theme. Kiwa Bio-Tech Products Group has its corporate office in Claremont, California.
Kiwa Bio-Tech’s commitment is to making safe food, further developing eco-agriculture, and upholding a responsibility of contributing to China's agricultural safety, food safety, and a healthy lifestyle. The Company’s dedication is to eco-agricultural development and environmental control through developing, producing, and selling bio-technological products with high technology, low-cost, and high productivity to satisfy rising market demand.
The design of its products is to enhance the quality of human life through boosting the value, quality, and productivity of crops and lessening the negative environmental impact of chemicals and other wastes. The Company utilizes new bio-technological skills at its core. Its new products structure includes 16 kinds of products in 5 major categories - Biological Organic Fertilizer, Compound Microorganism Fertilizer, Microorganism Bacterium Agent, Biological Soluble Fertilizer, and Organic-Inorganic Compound Fertilizer.
Kiwa Bio-Tech launched a joint venture (JV) with Zhongshi'an Agricultural Science & Technology Co., Ltd. and Xintaitianyi Financial Service and Science & Technology Co., Ltd. The name of the JV is Inner Mongolia Jingnong Investment Management Co. Ltd. Also, Kiwa Bio-Tech has established retail outlet stores in Shaanxi Province that distribute its fertilizer products.
Presently, the Government of China is providing significant financial support and is strongly promoting the integration of farming and breeding programs in rural areas. Kiwa Bio-Tech is presently in a lead position to provide eco-friendly planting techniques and fertilizer utilization methods that will contribute to the development of the program.
Additionally, the Company anticipates enhancing local farmers’ income. Kiwa Bio-Tech received approval from the Yangling Free Trade Zone in China to obtain land for the construction of a manufacturing facility to meet the US$16 billion-dollar increasing demand for bio-fertilizers in China over the next 5 years.
Kiwa Bio-Tech Products Group Corporation (KWBT), closed Friday's trading session at $0.79, up 38.5965%, on 1,075 volume with 4 trades. The average volume for the last 3 months is 4,082 and the stock's 52-week low/high is $0.270999997/$1.45000004.
EPHS Holdings, Inc. (STNN)
MarketWatch, YCharts, Dividend Investor, last10k, Simply Wall St, Stockopedia, The Stock Market Watch, The Street, Street Insider, Market Chameleon, Stockwatch, InvestorsHub, GuruFocus, Wallet Investor, Morningstar, and Marketbeat reported earlier on EPHS Holdings, Inc. (STNN), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
EPHS Holdings, Inc., via its subsidiary, Emerald Plants Health Source, Inc., intends to cultivate and distribute cannabis in Canada. The Company’s aim is to secure a commercial cultivation license identified as a license for access to cannabis for medical purposes regulation (ACMPR). OTCQB-listed, EPHS Holdings is headquartered in Boynton Beach, Florida.
Only upon receipt of the ACMPR may the Company commence its commercial operations. After Health Canada grants EPHS its ACMPR license, the Company will begin cultivation of its first cannabis crops.
The initial crops will be submitted to Health Canada as part of the Company’s application for a sales license. EPHS plans to begin commercial sales within four months of receiving the ACMPR license.
Emerald Plants Health Source is EPHS Holdings’ sole operating subsidiary. Emerald is based in the Province of Quebec. It conducts its operations entirely within Canada. Upon Emerald obtaining its ACMPR, it will be required to apply for an additional sales license.
This past October, EPHS Holdings, together with its joint venture (JV) partner, Merritt Valley Cannabis, announced it received approval for their pending commercial cultivation license, (ACMPR), from Health Canada. The license was received on Friday, October 12, 2018. EPHS may now produce cannabis for medicinal and recreational purposes. This includes licensed products such as dried or fresh cannabis flower, cannabis oil, starting materials and plants at EPHS’s state-of-the art facility in Quebec.
Also in October, EPHS Holdings, together with its JV partner, Merritt Valley Cannabis, announced its Montreal cultivation plans started, as per Health Canada sales license regulations and inspections. The EPHS state-of-the-art facility in Montreal is ready for immediate production and scale. EPHS is starting with the Health Canada sales license process.
EPHS will continue to scale cannabis production at its Merritt site with the granting of additional Health Canada licenses. Ground breaking is scheduled for early this year for Phase one of the 30,000 square foot Cannabis Campus. The expectation is that the campus will produce a supply of 5,500 plus kilograms of cannabis per year by early 2020.
EPHS Holdings, Inc. (STNN), closed Friday's trading session at $0.40, up 33.3333%, on 1,000 volume with 1 trade. The average volume for the last 3 months is 2,868 and the stock's 52-week low/high is $0.300000011/$4.40000009.
Black Cactus Global, Inc. (BLGI)
StreetInsider, Insider Financial, The Street, 4-Traders, Morningstar, Stockopedia, Dividend Investor, PennyStockHub, Stockhouse, Simply Wall St, MarketNewsUpdates, Tip Ranks, Stockwolf, Barchart, InvestingNewsAlerts, Stock Press Daily, InvestorsHub, OTC Markets, and InvestorsHangout reported previously on Black Cactus Global, Inc. (BLGI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Black Cactus Global, Inc. is a technology development business focusing on Blockchain, machine learning, cryptocurrency, and the Internet of Things (IoT). Its corporate mission is to pioneer the application of Blockchain and overlapping technologies to protect IP (Intellectual Property) and the security of data and financial transactions. The Company is developing Blockchain applications for FinTech, Healthcare, Media and Supply Chain employing smart contracts and machine learning. Black Cactus Global is based in Las Vegas, Nevada.
The Company’s strategic plan is to become the first totally integrated digital financial institution with Blockchain technology as its operating foundation. Black Cactus Global’s services include Blockchain Applications, Trading Exchange, KYC/AML Biometrics, Music Exchange, and Card Programs and Payment Systems.
In addition, its services include Crypto Currencies, Internet of Things (IoT), Smart Contracts, as well as FinTech & MedTech. Black Cactus Global specializes in worldwide development and consulting projects in its key development areas of FinTech, digital media, financial services, KYC, AML, cyber security, and healthcare.
Black Cactus Global announced in January of this year that it entered into an MOU (Memorandum of Understanding) with the majority shareholders in an Indian Technology firm to establish a subsidiary of the Company. With the MOU, Black Cactus Global will become the largest stakeholder of a global Technology company with offices in the ‘FinTech Valley’ Vizag Software Technology Park in Visakhapatnam, India, through which it will center on and advance the use of its innovative Blockchain based IP.
In May 2018, Black Cactus Global announced that it completed a share exchange agreement with the Blockchain development subsidiary, Black Cactus Global Technologies Pvt. Limited (BCG-TPL). The agreement calls for Black Cactus Global to own an initial 29 percent interest in BCG-TPL, which has already attained major milestones that will enable Black Cactus to scale-up development activities.
Regarding Healthcare, Black Cactus Global concentrates on creating opportunities for digital health economies via Blockchain with AI, IoT, and Machine Learning. Pertaining to Energy, the Company offers privatized network grid provision to isolate green energy from traditional energy sources and a chain code logic to manage energy distribution and estimation.
Black Cactus Global, Inc. (BLGI), closed Friday's trading session at $0.00655, up 42.3913%, on 40,563 volume with 6 trades. The average volume for the last 3 months is 23,631 and the stock's 52-week low/high is $0.000699999/$0.045000001.
Lexington Biosciences, Inc. (LXGTF)
Awesome Penny Stocks, Penny Stock Hub, MarketWatch, Morningstar, Interactive Brokers, TradingView, Dividend Investor, Tech Stock Insider, InvestorsHub, Wallet Investor, 4-Traders, and Market News Updates reported earlier on Lexington Biosciences, Inc. (LXGTF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
A medical device company, Lexington Biosciences, Inc. is developing the HeartSentry. This is a new non-invasive diagnostic device to measure and monitor cardiovascular health through assessing the function of a person's vascular endothelium. This is the vital innermost lining of a person's cardiovascular system. The Company’s aim is to become a leader in the development of clinical grade cardiovascular self-measurement solutions for home and clinical use. Lexington Biosciences has offices in Vancouver, British Columbia; and Reno, Nevada.
Lexington is engaged with the US FDA (Food and Drug Administration) and other regulatory agencies on the required product approvals for the HeartSentry. HeartSentry targets the fast-growing self-measurement medical device sector. The design of the HeartSentry unit is to use Bluetooth and Cloud technology to provide up-to-date and accurate readings of an individual’s total cardiovascular health via electronic monitoring for risk-assessment and treatment effectiveness targeting the prevention of heart attack and stroke.
HeartSentry is its flagship, and first device currently advancing to commercial deployment. The HeartSentry core technology underwent development at the University of California Berkeley over a fifteen-year research and development (R&D) period involving many research studies and product iterations resulting in a portfolio of numerous pending and issued patents licensed to Lexington Biosciences.
Lexington Biosciences announced earlier this year the completion of the initial HeartSentry study conducted at San Francisco Bay-area Diablo Clinical Research. Lexington Biosciences’ goal is to make HeartSentry accurate, fast, and cost effective so it can become the standard of care for cardiologists, general practitioners, and ultimately patients for first line evaluation of a person's cardiovascular health.
Over this past summer, Lexington Biosciences completed its first phase of clinical testing at Diablo Clinical Research. The results of the study validated safety protocols, provided Lexington with critical information for product iteration, algorithm development, and clinical testing protocol refinement in preparation for the forthcoming multi-center clinical study series.
Lexington Biosciences, Inc. (LXGTF), closed Friday's trading session at $0.085, up 30.7692%, on 18,298 volume with 7 trades. The average volume for the last 3 months is 7,323 and the stock's 52-week low/high is $0.018699999/$1.29999995.
Towerstream Corp. (TWER)
MadPennyStocks, MarketClub Analysis, Money Morning, PennyOmega, OTCBB Journal, OTCMagic, Penny Picks, KingPennyStocks, BUYINS.NET, Damn Good Penny Picks, Penny Stock Prodigy, CoolPennyStocks, Epic Stock Picks, Hit and Run Candle Sticks, HotOTC, Investing Futures, MicroCapDaily, Investment Contrarians, Jason Bond, Broad Street, BullRally, PennyInvest, and ChartPoppers reported on Towerstream Corp. (TWER), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Towerstream Corp. is a leading Fixed-Wireless Fiber Alternative business. The Company delivers high-speed Internet access to businesses. Together with its subsidiaries, it provides fixed wireless broadband services and delivers access over a wireless network transmitting over regulated and unregulated radio spectrum to commercial customers in the United States. Towerstream has its corporate office in Middletown, Rhode Island.
Towerstream announced earlier in 2018 that its Board of Directors started evaluation of strategic repositioning of the Company as it moves to take advantage of its existing important assets in major American markets. In association with the announcement, Towerstream launched a determined focus on indirect and wholesale channels and the retention of Bank Street Group LLC as its independent financial advisor to explore strategic alternatives with such broadband carriers.
Towerstream provides broadband services in twelve urban markets. These include New York City, Boston, Los Angeles, Chicago, Philadelphia, the San Francisco Bay area, Miami, Seattle, Dallas-Fort Worth, Houston, Las Vegas-Reno, and the greater Providence area. Towerstream has constructed 175 Major Points of Presence (POPs). The Company positions its POPs on the tops of buildings.
Towerstream is a last-mile facilities-based provider. It owns its entire network. The Company totally bypasses the local exchange carrier and cable providers. Its solution to businesses either complements or replaces existing Internet connections. Towerstream provides property managers, building owners, and their commercial tenants a redundant and reliable dense urban network. This network directly connects to the Company’s fiber backbone.
Towerstream has its Single Tenant Internet Solution. This solution is for customers not in On-Net buildings. The Single Tenant Internet Solution provides primary and back-up dedicated internet access as a faster and less expensive alternative to fiber. On-Net refers to the extensive number of buildings in Towerstream’s 12 coverage markets now lit for On-Net Business Internet Service. The Company’s On-Net Service provides businesses within its continually growing portfolio of On-Net buildings with dedicated and symmetrical Internet connectivity.
Towerstream Fixed Wireless features fast installation, guaranteed 99.99 percent uptime backed by the Company’s industry leading SLA, and scalability. It also features faster than fiber, true redundancy, and symmetrical speeds.
Towerstream Corp. (TWER), closed Friday's trading session at $0.99, up 98.00%, on 209 volume with 6 trades. The average volume for the last 3 months is 229 and the stock's 52-week low/high is $0.50/$3.50999999.
Sustainable Projects Group, Inc. (SPGX)
Infront Analytics, OTC Markets, Wallstreet Online, OTC Dynamics, Capital Cube, Market Exclusive, MarketWatch, Simply Wall Street, TradingView, OilandGas360, and 4-Traders reported on Sustainable Projects Group, Inc. (SPGX), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Sustainable Projects Group, Inc. is a member of SP Group. Sustainable Projects is positioned to become a world leading natural resources holding and development company through value-based investments and collaborative partnerships with global leaders across the natural resources sector. SP Group has initiated its goals through pursuing investment and partnerships with some of the most diversified and integrated companies available on the market. OTCQB-listed, Sustainable Projects Group has its corporate office in Naples, Florida.
The Company is to invest into undervalued global companies via direct investment. Also, it is negotiating investment and collaboration agreements with different international leaders throughout the natural resource industry.
SP Group’s commitment is to negotiating working interests (WIs) in a broad array of natural resource projects worldwide. The Company uses the local knowledge and expertise of companies that operate its interests. Consequently, it benefits as non-operators from low-risk opportunities to provide a steady stream of resources to the global market.
SP Group chooses its investments and partnerships only from well established companies with a proven track record and that bring strong project experience to the Company. At present, SP Group is invested in a range of natural resources projects beyond its initial emphasis on oil and gas. Sustainable Projects Group announced in December 2017 the acquisition of myfactor.io AG. This is a business development company based in Liechtenstein.
Sustainable Projects Group is gaining direct access to a company with the experience and infrastructure to develop SME's and issue bonds. As part of its growth strategy for SME's, myfactor.io can place bonds in U.S. Dollars, Euros and Swiss Francs.
Sustainable Projects Group announced this past February the acquisition of a 10 percent stake in Falcon Projects AG. Falcon specializes in bridge financing and refinancing solutions in the construction and project development industry. With this acquisition, Sustainable Projects Group continues to broaden its network of investments and partners in varied industries. Headquartered in Zurich, Switzerland, Falcon Projects AG is presently providing financing solutions to a host of real estate development projects initiated by some of Europe's top project developers.
Sustainable Projects Group, Inc. (SPGX), closed Friday's trading session at $3.01, up 100.6667%, on 300 volume with 3 trades. The average volume for the last 3 months is 225 and the stock's 52-week low/high is $1.00/$3.29999995.
Bravo Multinational, Inc. (BRVO)
RedChip, InvestorsHub, and MarketWatch reported on Bravo Multinational, Inc. (BRVO), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Bravo Multinational, Inc. is a diversified Company listed on the OTC Markets Group’s OTCQB. Its primary focus is the development and expansion of the Casino Gaming Equipment holdings and business-related activities in Central and South America (specifically Nicaragua, El Salvador, and San Andres, Columbia). The Company’s multi-divisional growth strategy is driven via mergers, acquisitions, as well as new ventures.
The Company previously went by the name Goldland Holdings Co. It changed its corporate name to Bravo Multinational, Inc. in April 2016. Bravo Multinational has its head office in Niagara-on-the-Lake, Ontario.
At present, Bravo Multinational has divisions in Mining Properties and Casino Equipment. The Company, as it develops, will be adding divisions in International Business Consulting, Wholesale and Manufacturing, and Real Estate Acquisitions. In addition, Bravo holds gold/silver mining properties and claims in North America.
Pertaining to Mining Assets, this involves War Eagle Mines, Silver City, Idaho. Bravo executed a lease agreement with Silver Falcon Mining. This agreement provides for a yearly lease payment of $1,000,000 payable in monthly installments of $83,333 per month, and a royalty equal to 15 percent of the proceeds of any ore mined from Bravo Multinational property on War Eagle Mountain.
The Company’s Mining Assets (Current Claims) include the Poorman Lode Claim – Ownership Interest (OI) 29.167 percent; the London Lode Claim – OI 29.167 percent; the North Empire Lodge Claim - OI 29.167 percent; and the Illinois Central Lode Claim - OI 29.167 percent.
Current Claims also include the South Poorman Lode Claim – OI 29.167 percent; the Jackson Lode Claim - 29.167 percent; and the Oso Lode Claim - 29.167 percent.
Concerning Casino Gaming, Bravo completed an acquisition transaction on May 6, 2016 with Centro de Entretenimiento y Diversion Mombacho S.A., based in Managua, Nicaragua. Bravo received its first income from this business venture on June 1, 2016. Additional income payments will be received on the first of each month.
Regarding this transaction, the Company is purchasing, in total, 500 slot and video poker gaming machines. All machines have been fully nationalized and are to be operated under a long-term (year 2033) nationwide national license.
On August 16, 2017, Bravo completed an asset purchase for 300 slot and video poker machines. This provided an immediate new revenue stream for the Company.
The value of the contract is $3,618,000. The Company expects a roughly 30 percent annual return on the assets in Latin America, based on historical income data in comparable locations.
Bravo Multinational announced in August of 2017 its current review of a potential new “Casino Gaming” operation venture. Moreover, the Company announced its review of diversified business opportunities in the legalized marijuana (MJ) sector in Canada.
The Company commenced a comprehensive review of a large pending commercial “Marijuana Grow” operation with related real estate holdings for a possible joint venture (JV) investment, in Central Ontario, Canada. The licensing process for this venture is currently pending Health Canada’s government approvals.
Bravo Multinational, Inc. (BRVO), closed Friday's trading session at $0.50475, up 44.2143%, on 116 volume with 2 trades. The average volume for the last 3 months is 3,576 and the stock's 52-week low/high is $0.046/$0.949999988.
The QualityStocks Company Corner
- Pressure BioSciences Inc. (PBIO)
- Predictive Oncology (NASDAQ: POAI)
- ChineseInvestors.com (CIIX)
- VPR Brands, LP (VPRB)
- Spectrum Global Solutions, Inc. (SGSI)
- Geyser Brands Inc. (TSX.V: GYSR)
- Sharing Services Global Corporation (SHRG)
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
- The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
- TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8)
- HTC Extraction Systems (TSX.V: HTC)
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
- Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF)
Pressure BioSciences Inc. (PBIO)
Pressure BioSciences, Inc. (OTCQB: PBIO) is engaged in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry, according to the company’s website (click here: www.pressurebiosciences.com). SNNLive caught up with Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. at RHK Capital's 2019 Disruptive Growth Company Showcase in New York City, NY, and they discuss the following topics:
Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.
The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.
Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”
Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.
The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.
Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.
This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.
The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.
Pressure BioSciences Inc. (PBIO), closed Friday's trading session at $2.725, up 0.183824%, on 1,207 volume with 12 trades. The average volume for the last 3 months is 11,612 and the stock's 52-week low/high is $1.25/$4.0999999.
- VIDEO Update: Pressure BioSciences, Inc. (OTCQB: PBIO)
- Pressure BioSciences Inc.’s (PBIO) Patented PCT Platform Highlighted in 10 Separate Presentations at International Human Proteome Organization World Congress
- Pressure BioSciences Inc.’s (PBIO) Proprietary Technology Platform Identified as Key Cancer Biomarker Research Element
Predictive Oncology (NASDAQ: POAI)
Predictive Oncology (NASDAQ: POAI) is assisting clinicians and researchers in improving outcomes for cancer patients via its AI-driven, tumor-profiling platform. To view the full article, visit http://nnw.fm/pV2Fc.
Predictive Oncology (POAI) is a data and artificial intelligence-driven discovery services company that provides predictive models of tumor drug response to improve patient outcome. Predictive Oncology harnesses the power of artificial intelligence, collaborating with the pharmaceutical, diagnostic and biotech industries to develop highly customizable assessment methods for patients, which can lead to much more effective treatments.
Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.
Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.
In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.
TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells bind to specific biomarkers. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable development of patient specific treatment options.
Skyline Medical’s patented, FDA-cleared STREAMWAY System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.
The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.
Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.
Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.
CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.
Predictive Oncology (POAI), closed Friday's trading session at $0.5901, up 4.535%, on 91,123 volume with 119 trades. The average volume for the last 3 months is 60,289 and the stock's 52-week low/high is $0.419999986/$0.850000023.
- Predictive Oncology Inc. (NASDAQ: POAI) Bringing Precision Medicine Tools to Physicians
- Predictive Oncology Inc. (NASDAQ: POAI) Transforming Cancer-Treatment Outcomes via Proprietary Database
- Coverage Initiated for Predictive Oncology via NetworkNewsWire
Established financial news and investment portal for the global Chinese-speaking community ChineseInvestors.com (OTCQB: CIIX), through its division CBD Biotech Inc., is concentrating on cannabidiol (CBD)-based nutrition and health products. To view the full article, visit http://cnw.fm/z6bBp.
Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.
Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.
At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.
CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.
The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.
Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.
In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.
ChineseInvestors.com (CIIX), closed Friday's trading session at $0.26935, up 3.5962%, on 8,480 volume with 14 trades. The average volume for the last 3 months is 47,082 and the stock's 52-week low/high is $0.25/$1.25.
- ChineseInvestors.com Inc. (CIIX) Focusing on CBD-Based Nutrition, Health Products
- ChineseInvestors.com Inc. (CIIX) MicroCap Presentation Well Received, CBD Future Bright
- ChineseInvestors.com Inc. (CIIX) Announces 175% Sales Increase, Launch of Six New Hemp-Infused Skincare Products
VPR Brands, LP (VPRB)
VPR Brands LP (OTCQB: VPRB) is a technology holding company that fosters brands via direct sales and licensing opportunities in the CBD (cannabidiol) vertical. A unique technology enterprise, the company’s assets include patented atomization-related products and technology. VPR Brands had full-year revenues of approximately $4.6 million in 2018 (http://cnw.fm/NEwA7). For Q1 2019, its quarterly revenues increased approximately 31 percent year-over-year to $1.3 million (http://cnw.fm/d83P3).
Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.
VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:
- GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit www.cbdgoldline.com.
- HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit www.vapehoneystick.com.
- Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
- Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
- Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
- GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit www.goldlinehemp.com for more information about GoldLine Hemp-only products.
- Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.
CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.
Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.
VPR Brands, LP (VPRB), closed Friday's trading session at $0.045, up 7.1429%, on 126,540 volume with 10 trades. The average volume for the last 3 months is 141,245 and the stock's 52-week low/high is $0.033799998/$0.119999997.
- VPR Brands LP (VPRB) CEO is Significant Stockholder in Company, Indicating Confidence in Future Potential
- VPR Brands LP (VPRB) to Debut Premier GOLDLINE CBD Products at NACS 2019
- VPR Brands LP (VPRB) Gearing Up to Launch Vape Battery Line
Spectrum Global Solutions, Inc. (SGSI)
Telecommunications network service provider Spectrum Global Solutions Inc. (OTCQB: SGSI) announced recently that it has succeeded in renewing a key contract with a U.S.-based tier 1 carrier to which it has previously provided outside plant labor, construction and maintenance services.
Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:
- AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
- ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
- Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.
Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.
Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.
CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.
Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.
Spectrum Global Solutions, Inc. (SGSI), closed Friday's trading session at $0.0249, up 0.080386%, on 31,349 volume with 6 trades. The average volume for the last 3 months is 180,361 and the stock's 52-week low/high is $0.014999999/$1.49.
- Spectrum Global Solutions Inc. (SGSI) Secures Key Tier 1 Contract Renewal Amid Ongoing 5G Services Buildup
- Spectrum Global Solutions Inc. (SGSI) Cuts More Than $800 Thousand in Convertible Debt
- Spectrum Global Solutions Inc. (SGSI) Prepared to Support 5G Technology
Geyser Brands Inc. (TSX.V: GYSR)
Geyser Brands Inc. (TSX.V: GYSR) is a consumer healthcare company that builds and markets some of the world's most loved cannabis products and brands in the nutraceutical, cosmetics, food and beverage and pet sectors. Using its proprietary nanotechnology formulation, the company delivers creams, beverages, baked goods and tincture formulations with superior bioavailability and water solubility.
The efficacy of most hemp?products is restricted as the insoluble nature of the molecules prevents most of the product from permeating the skin or entering the body system. Geyser Brands solves this insolubility problem with an advanced delivery system that quickly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency.
Made with all-natural materials, NanoFusion technology offers an array of advantages: enhances penetration for deeper skin penetration; improves the transport of active ingredients for site-specific targeting; delivers active ingredients across cell membranes for release within the cell; provides longer shelf-life and stability of molecules.
Geyser Brands operates a 7,000-square-foot facility in Port Coquitlam, British Columbia, where its initial cannabis cultivation generated the first revenues out of the company's cultivation license granted in October 2018. Geyser Brands is approved as a licensed producer in compliance with Health Canada standards, which allows the company to pursue its processing and sales license. Obtaining this license will enable the company to extend its products and brands into the regulated Canadian cannabis market and directly to the consumer medical market.
Geyser Brands's integrated production chain and formulation lab develops innovative products using high-quality hemp and CBD for healthy lifestyle brands while its R&D lab produces product formulations designed to enhance bio-availability of hemp and CBD and shelf stability while maintaining all-natural ingredients and ensuring premium quality.
Geyser Brands will continue to seek opportunities to invest into the research and development of unique high-quality proprietary strains and technologies that target specific health-related conditions such as pain and inflammation reduction, insomnia, digestive issues and other commonly known ailments.
Among the brand formulations in Geyser Brand's portfolio are:
- Apothecary all-natural Hemp Terpene Pain Cream with optimal skin permeation
- Prohibition Cold Brew Mocha designed with water soluble hemp molecules
- Apothecary health products created to deliver fast-acting and high bioavailability in a spray formulation
- Baked hemp infused pet products, designed to alleviate anxiety and pain, created with NanoFusion for dosage control
Since 2014, Geyser Brands' CEO and Co-Founder Andreas Thatcher has been a principal at Rhizome Group, an entertainment company focused on building media IP through creative and market development. He previously was a founding partner at Rhizome Capital LLC, a U.S.-based media?investment?company specializing in marketing and distribution financing, and worked in the Investment Banking industry in?London and Toronto. Thatcher holds a master's degree in economics.
CFO Barry McKnight obtained his bachelor's degree from the University of British Columbia and is a Chartered Professional Accountant and?Certified Management Accountant registered in British Columbia. McKnight has over 20 years of experience as the principal of Barry D. McKnight Inc. He formerly was also a director of Indigo Sky Capital Corp. and has been the CFO and a director of the Company since 2016 and Corporate?Secretary of the Company since 2017.
Geyser Brands's Co-Founder Brad Kersch brings a strong business background with over 20 years of experience in?successful startups and working?with Fortune 500 companies. He spent his early years in the advertising and?marketing field and went on to form Hyperware, a clothing?company that sold branded clothing to retailers across Canada?before selling to clothing giant Ocean Pacific (OP). Kersch?became the president of Shoreline Studios, Canada's largest and?oldest?studio for film and TV. In 2014 he started Solace Management Group, a hemp product company focused on pet, cosmeceutical, and nutraceutical markets. As of February 2019, Geyser Brands signed a non-binding LOI to acquire Solace Management. Upon completing the proposed Solace acquisition, Geyser Brands intends to launch into the execution phase of its plan — to take its brands global through retail and digital direct-to-consumer experiences, launching its hemp-infused cannabis brands and products in the U.S., European Union, and Asia, and its CBD-infused line of products in jurisdictions where the therapeutic ingredient is legal.
Kuldip Gill, head of Geyser Brands' R&D program, has more than 35 years of experience in the cannabis industry. Gill built the largest manufacturing facility?in the lower mainland in Surrey, British Columbia, complete with R&D, analytical and quality control labs approved by both the FDA and Health Canada. He has to date created over 3,500 formulas, most notably Lakota pain relief gel. Gill's experience and proven track record is evident in the strongly marketable formulations he has developed and sold worldwide.
Geyser Brands Inc. (TSX.V: GYSR), closed Friday's trading session at $0.49, even for the day, on 500 volume. The average volume for the last 3 months is 2,373 and the stock's 52-week low/high is $0.409999996/$0.850000023.
- Geyser Brands Inc. (TSX.V: GYSR) Achieves 81% Gross Profit Margin in Q1 2019
- Geyser Brands' Subsidiary Receives Natural Health Product Number from Health Canada
- Geyser Brands Inc. (TSX.V: GYSR) Demonstrates Growth with Encouraging Financial Results
Sharing Services Global Corporation (SHRG)
Sharing Services Global Corporation (OTCQB: SHRG), a diversified holdings company, recently held its annual shareholder meeting and announced shareholder election results. To view the full article, visit http://nnw.fm/RS5vn.
Sharing Services Global Corporation (SHRG), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRG has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.
Sharing Services Inc. subsidiaries include:
- A growing international network of home-based entrepreneurs, called “Elepreneurs”
- Growing selection of health and wellness products dedicated to elevating the well-being of all people
- Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
- Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
- Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
- Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness
Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.
“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”
The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.
Nearly 1,000 people attended Sharing Services Global Corporation ’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.
“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”
Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.
The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services Global Corporation , and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.
John “JT” Thatchwas appointed president and chief executive officer of Sharing Services Global Corporation , at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.
Sharing Services Global Corporation (SHRG), closed Friday's trading session at $0.15, even for the day, on 13,000 volume with 2 trades. The average volume for the last 3 months is 33,038 and the stock's 52-week low/high is $0.090000003/$0.3944.
- Sharing Services Inc. (SHRG) Shareholders Elect Board Members, Ratify Accounting Firm at Annual Meeting
- Sharing Services Global Corporation (SHRG) Growing Global Network, Adds Thousands of Independent Representatives
- Sharing Services Global Corporation (SHRG) Announces Shareholder Election Results
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) was highlighted today in a publication from Wall Street PR, examining how the cannabis space is targeting some relatively remarkable growth estimates, with analysts routinely jacking up forecasts. But two dynamics have made it increasingly difficult for investors in the space: the increasing supply along with demand to suit the process of legislative and mainstream adoption has pressured cannabis pricing, and the enthusiasm of investors along the way has created some valuation issues that have led to significant pain for poorly timed entries.
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint.
The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.
In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.
Significant Expansion Plans with Streamlined Licensing Process
Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.
In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.
The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.
Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.
Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products
Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.
Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.
Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.
The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.
Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.
Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.
Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.
Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.
Experienced Executive Team
- CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
- Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
- Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
- Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
- Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.
This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.
1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.
Organigram Holdings Inc. (NASDAQ: OGI), closed Friday's trading session at $3.67, off by 0.542005%, on 1,472,885 volume with 4,073 trades. The average volume for the last 3 months is 1,084,565 and the stock's 52-week low/high is $2.97000002/$8.43999958.
- Comparing Leading Cannabis Stocks in a Stockpicker’s World (TLRY, MDCL, OGI)
- BTV Uncovers Companies in the Growing Cannabis Sector
- 3 Brand-Name Cannabis-Infused Beverage Stocks You Need to Know
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified-organic cannabis, is on a mission to meet the growing demand for organic cannabis in Canada. To view the full article, visit http://cnw.fm/n0hF3.
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).
Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.
TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.
Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.
Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.
The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.
The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.
TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.
Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.
Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.
TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.
To learn more about the company and how to invest, contact TGOD directly at firstname.lastname@example.org
The Green Organic Dutchman (OTC: TGODF), closed Friday's trading session at $1.70, off by 3.9548%, on 681,780 volume with 632 trades. The average volume for the last 3 months is 664,329 and the stock's 52-week low/high is $1.60699999/$5.63999986.
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Advances Within Competitive Canadian Cannabis Space
- 420 with CNW – UK Experts Want Medical Marijuana Free for All
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Confirms Robust Demand for Premium Organic Cannabis
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a diversified portfolio of cannabis brands that deliver positive experiences, continues to expand through several brand offerings designated for its discerning customer base. Through its various brands, SPRWF continues to synthesize its consumer-driven approach with a strong foundation of business fundamentals to realize promising revenue goals.
Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”
Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.
In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.
“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”
The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.
Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.
7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.
Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.
Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.
To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.
Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.
Supreme Cannabis Company Inc. (OTC: SPRWF), closed Friday's trading session at $0.95, off by 3.1896%, on 376,465 volume with 403 trades. The average volume for the last 3 months is 413,560 and the stock's 52-week low/high is $0.850000023/$1.79999995.
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Launches Proprietary Jack Haze Strain
- 420 with CNW – UK Experts Want Medical Marijuana Free for All
- Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Expanding Globally through Strategic Partnerships
TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8)
TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) was featured today in a publication from HempWireNews. Did you know it’s possible to make a flashy sports car with industrial hemp? In 1941, Henry Ford pioneered the concept of making plant-based vehicles, which were set to revolutionize the automotive industry. However, this wasn’t taken any further, until this year when the first hemp car rolled off the production line. Also today, the company was highlighted in a publication from CBDWire, examining how when lawmakers passed the Nebraska Hemp Act, the local business community was thrown into confusion because it wasn’t clear whether CBD was legal to sell or not. Currently, each county has its own opinion on the matter, and this has caused one small business owner to make the hard decision to open his CBD business in one county and not another where he would have preferred to set up shop.
TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) brings together a rapidly growing portfolio of cannabis and hemp-related brands and services, with a closed-loop ecosystem approach rooted squarely in the company’s ownership of a 196,000-square-foot, vertically integrated facility in California. The company has developed a two-year, four-phase plan aimed at developing proprietary brands and creating a self-contained ecosystem that ensures reliability, consistency, quality and scale.
TransCanna’s cannabis facility in Modesto, California, is strategically located less than a three-hour drive from the majority of all major cities in the state. The tri-level building provides internal control of everything needed for the seed-to-sale cycle, from growing and manufacturing to extraction, bottling, transportation and distribution. The facility, which recently went through an US$8 million renovation, is upgraded with a premium quality HVAC system and highly insulated roof to help reduce power costs, which already are some of the lowest in California.
The company has set 2020 goal for implementation of its full-service software platform, 420 Global, which will interact with every aspect of production flow, business development and the sales process.
Acquisitions slated to be completed in June include Goodfellas Group LLC, a full-service advertising and marketing agency for the U.S. cannabis and hemp industries. Under the deal, TransCanna will also be acquiring Daily Cannabis Goods, a pre-rolled brand with nominal start-up costs and superior SKU velocity with cannabis products available at more than 30 dispensaries throughout California.
The company has moved to acquire organic hemp-infused CBD coconut oil Biovelle (www.Biovelle.com). Biovelle is non-GMO, vegan and gluten free, with coconut sourced from plantations in the Philippines and American grown hemp from farms in Colorado.
TransCanna has also moved to further secure a growing foothold in cannabis edibles via a non-binding letter of intent with Persuasion Brewing Co., located near the company’s flagship facility in Modesto. The goal is to establish a Persuasion Brewing division at the main facility, which will produce a variety of different CBD infusion non-alcoholic beers.
Similarly, the company has recently executed a non-binding LOI with SolDaze (Tres Ojos Naturals, LLC) to gobble up the branding asset package of this California manufacturer of cannabis-infused fruit snacks (www.soldazesnacks.com).
TransCanna’s management team consists of seasoned agriculture and consumer goods-oriented veterans.
Director, CEO and Chairman James Pakulis has 30 years of experience working with public and private entrepreneurial companies in a variety of emerging sectors. He has been on the front lines of the California cannabis industry for nearly a decade. He was CEO and chairman in 2010 of General Cannabis, Inc., which wholly owned the popular Weedmaps brand. Pakulis oversaw the growth of General Cannabis from pre-embryonic stages to over $16 million in revenue in less than two years, reaching a market cap of approximately $480 million.
Director and President Arni Johannson brings over 30 years of investing experience in the Canadian capital markets. He has built and or funded over 50 startups from around the world. He is president of Canadian Nexus Ventures and has been instrumental in providing guidance to pre- and post IPO companies, as well as guidance and oversight for corporate governance.
Stephen Giblin, board director, is an accomplished leader in the global hospitality, technology and real estate industries with a demonstrated track record of value creation. Juan Pablo Flores, independent director, is an attorney with more than 25 years of legal experience with a strong background in municipal, government, real estate, corporate and general civil law litigation.
The company’s strategic advisors include individuals with extensive experience in branding, marketing, sales, distribution, production and supply chain management.
TransCanna Holdings Inc. (CSE: TCAN), closed Friday's trading session at $0.77, off by 3.75%, on 141,500 volume with 32 trades. The average volume for the last 3 months is 146,791 and the stock's 52-week low/high is $0.629999995/$7.78999996.
- Hemp Sports Car Set to Revolutionize the Auto Industry
- Confusing Nebraska CBD Laws Prompt Business Owner to Cross County Lines
- TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) Completes SolDaze Acquisition
HTC Extraction Systems (TSX.V: HTC)
HTC Extraction Systems (TSX.V: HTC) today announced that it has repriced its “bought deal” brokered private placement that was originally announced on July 3, 2019 to reflect the current market price of the company's common shares. To view the full press release, visit http://cnw.fm/wu01F.
HTC Extraction Systems (TSX.V: HTC) has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp biomass and cannabidiol (“CBD”) industry, as well as gas and liquid extraction. HTC’s extraction & purification systems are engineered to large-scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced.
Advanced Extraction Technologies
For more than 14 years, HTC has developed and optimized proprietary technology and purification systems used for biomass, gas and liquid extraction. These technologies include:
- LCDesign® – Low-cost design for modular gas, liquid and biomass extraction systems optimizes plant design, thus reducing capital and operating costs.
- PDOEngine™ – Software-based design algorithms accurately model and simulate gas, liquid and biomass extraction processing.
- Delta Solvents™ – Custom-designed, ethanol-based solvent mixtures and additives that optimize production and reduce costs. Technology development is being conducted at HTC’s sponsored research facilities at the University of Calgary.
Delta Purification® Technology
HTC’s patented Delta Purification® technology will purify, recycle and reuse the extraction ethanol used in the CBD extraction process while managing and reducing any CBD waste losses through the re-extraction of all wastes collected from the purified ethanol. Current and new technologies include:
- Delta CBD Reclaiming System: Reclaiming and purifying ethanol for use in CBD extraction from biomass. Reduces required heat to prevent damage of the chemical attributes of the CBD molecule, allowing extracted CBD to meet food-grade targets for human consumption.
- Delta Solvent Reclaiming System: Reclaiming and purifying ethanol-based solvents, such as single, mixed and formulated amines, for use in natural gas processing and post-combustion CO2 capturing processes.
- Delta Glycol Reclaiming System: Reclaiming and purifying glycols, such as mono-ethylene glycol and tri-ethylene glycol for use in natural gas dehydration processes.
Hemp Biomass and Tolling Contracts
HTC has entered into a hemp biomass tolling agreement for the 2019 crop year involving a supply of hemp biomass from a hemp grower in Saskatchewan, Canada. The hemp grower utilizes five varieties of Health Canada-approved cultivars as the genetic foundation. HTC will process and extract CBD FSO distillate from the hemp biomass. As a tolling fee payment, HTC will receive a percentage of the extracted CBD FSO distillate for its processing, extraction, purification and distillation services.
Additional hemp biomass tolling contracts with producers and hemp biomass providers are being negotiated in the U.S. for the 2020 hemp crop growing year. HTC will provide “local-to-grower” drying-to-biomass storage capability and transportation of dried biomass to an HTC, location to be determined, future US based, extraction facility. HTC is also in negotiation with a 60,000-acre, recognized Canadian farm leader, who is a significant hemp biomass producer, for a similar hemp biomass tolling contract.
Large users of ethanol and solvents for plant oil extraction demand reduced capital and operating costs. HTC’s re3™ (reclaim, recycle, reuse) technology can save up to 30% of the required fluid costs. The increasing cost of new extraction ethanol, combined with the cost of used ethanol disposal, creates a unique opportunity whereby the re3™ technology will create cost savings, while meeting environmental responsibilities.
The growth of ethanol and CO2 used in CBD production has created a new demand for reliable commercial scale ethanol reclaimer systems. The Delta Purification® ethanol system meets this new demand.
Sales and Offtake Agreements
HTC intends to leverage its relationship with its related entity, Purely Canada Foods™, to provide sales and distribution for its Ingredient CBD market under the brand of Purely Canada Hemp™, Purely Canada CBD™, Purely Canada Cannabinoids™. Purely Canada Hemp™ will develop risk managed multi-year ingredient supply contracts with its existing and new Global Food, Beverage and Animal Food Industry Customers.
HTC has focused the Canadian implementation of its BOOM (build, own, operate and maintain) extraction tolling strategy on a location near Regina, Saskatchewan. HTC is currently constructing a 19,000-square-foot GMP Euro compliant extraction tolling facility on six acres of land that will include biomass processing, extraction, implementation of DeltaSolv™ technologies and Delta Purification® systems, distillate and refining equipment, laboratory quality control and testing operations, and on-site office and admin facilities.
Chairman, CEO and Director Lionel Kambeitz is a recognized professional in business development and international business relations. He has played a founding role in many other Canadian and U.S.-based companies. Kambeitz has executive experience in a variety of industries including energy, agriculture, food production engineering, and manufacturing.
Jeff Allison, Senior Vice President, Chief Financial Officer and Director, has over 20 years of experience in corporate finance and business development. Prior to joining HTC in 2005, Allison as Vice President assisted with the founding and setup of CUCORP Financial Services in Saskatchewan.
HTC Extraction Systems (TSX.V: HTC), closed Friday's trading session at $0.315, off by 21.25%, on 762,269 volume with 133 trades. The average volume for the last 3 months is 190,751 and the stock's 52-week low/high is $0.079999998/$1.24.
- HTC Extraction Systems (TSX.V: HTC) Reprices Private Placement
- 420 with CNW – Marijuana Banking Bill Changes Suggested to Win Republican Support
- HTC Extraction Systems (TSX.V: HTC) Securing Several Hemp Biomass Tolling Contracts
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
Wildflower Brands (CSE: SUN) (OTCQB: WLDFF), a public cannabis company developing brands that focus on plant-based wellness and health products, executed an agreement to purchase all issued and outstanding shares of City Cannabis, which recently announced two more store openings (http://cnw.fm/8nC5i). To view the full article, visit http://cnw.fm/Hho4U.
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.
Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.
Gathered within the growing family of Wildflower brands are the following entities:
- Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
- King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
- Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.
Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.
Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.
In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company Eaze.com to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.
Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.
William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.
CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.
Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.
Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.
Wildflower Brands Inc. (WLDFF), closed Friday's trading session at $0.2698, off by 15.9502%, on 5,800 volume with 4 trades. The average volume for the last 3 months is 11,261 and the stock's 52-week low/high is $0.250999987/$1.00.
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Subsidiary Opens Two New Premier Cannabis Locations
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Developing Robust Retail Network for CBD Products
- 420 with CNW – Massachusetts Lawmakers Move to Address Vaping Dangers
Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF)
Chemistree Technology (CSE: CHM) (OTCQB: CHMJF)on Thursday announced its support for the passage of the Secure and Fair Enforcement Banking Act of 2019 (“SAFE Banking Act”) by the United States House of Representatives. The SAFE Banking Act is anticipated to be voted on by the U.S. Senate by the end of the year. To view the full press release, visit http://cnw.fm/zaT1e.
Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF), an investment company focused on the U.S. and international cannabis sectors, provides turnkey solutions for the regulated cannabis industry. The company leverages managements' expertise and decades of experience in the cannabis industry to acquire and develop vertically integrated cannabis assets. Chemistree recently closed on a purchase of prospective cannabis cultivation property in California, made a first investment in the Canadian cannabis industry, owns assets in the State of Washington used to operate an established retail cannabis brand, and has an active pipeline of assets in place to grow its portfolio.
Chemistree offers industry leading expertise across all areas the cannabis business and in its growth as a public or private company.
- Investment and funding for rapid growth
- Vertical integration solutions
- Construction, design and/or optimization of indoor or outdoor cultivation facilities
- Reputation management & influencer outreach
- Branding and Packaging
- Social Media and Media outreach
With the marketing of cannabis companies and their products in its infancy, the company believes the industry offers tremendous opportunity for growth in the U.S. and abroad. Chemistree initially targeted the Pacific Northwest for investment and, following its recent California property purchase, expects to expand vertically across the United States in areas where it has a competitive business advantage.
Through its wholly owned CHM Desert LLC subsidiary, Chemistree owns 9.55 acres of undeveloped land in Desert Hot Springs, California. The property is zoned as Light Industrial Lands Designated for Marijuana Cultivation, and local zoning ordinances allow as a conditional use the location of up to three onsite cannabis cultivation buildings of 68,000 square feet each, along with support space that would support production of 55,000 pounds/year.
Through its wholly owned Chemistree Washington Ltd. subsidiary, Chemistree acquired physical assets used in the cultivation, production and distribution of cannabis. The Washington assets are currently under lease to Sugarleaf Farm LLC, which operates the Sugarleaf brand of retail cannabis products in the State of Washington. Sugarleaf Farm is a Tier 3 cannabis producer and processor whose products are sold in about 125 retail outlets. Chemistree has indicated the relationship with Sugarleaf may provide the company with additional opportunities to become involved in the marketing of Sugarleaf products.
Chemistree funded these acquisitions and investments with the proceeds of two non-brokered private placement financings completed earlier this year under the regulations of the Canadian Securities Exchange, totaling CAD$4.5 million. In conjunction with the private placements, the company was granted approval by the CSE for a change of business to become an Investment Issuer. This funding is expected to provide the company "maximum flexibility to take advantage of the numerous opportunities available in the cannabis industry in Canada and the U.S."
Chemistree also has a strategic investment in Pasha Brands Ltd., a British Columbia based cannabis company with multiple internationally recognized brands. Pasha has a proven history in cannabis retailing and its proposed Licensed Processing (LP) facility on Vancouver Island is in the final stage of the application for government approval. The LP facility is expected to assist in licensing selected craft growers of cannabis and expanding the distribution of locally grown product. The investment represents less than 10% of Chemistree's working capital.
Company Chairman Justin Chorbajian is co-owner of the largest chain of privately owned hydroponic retail shops in Canada. He also cofounded a group of companies that manufacture and distribute hydroponic equipment. He is a frequent contributor to Growing Exposed, the leading video series dedicated to cannabis cultivation. Company President Karl Kottmeier is a former investment advisor with 20 years of experience listing, financing and administering companies on the Toronto Stock Exchange and TSX Venture Exchange. He has raised more than $150 million in equity capital for ventures. Chemistree CFO Doug Ford has been general manager of Dockside Capital Group Inc., a private merchant banking and venture capital firm serving emerging growth companies. Sheldon Aberman, the most recent member of the Board, has managed, designed and created industry leading grow room designs around the world. Additionally, he has built several leading brands such as Frost Box and Black Label and is an expert in the accessory market (vape pens, silicon mats and extraction tools etc.).
Data firm Statista has forecast the U.S. legal cannabis market will be worth more than $24 billion by 2025. New Frontier Data, which focuses exclusively on the cannabis industry, projects the value of the Canadian domestic cannabis market that same year at CAD$9.2 billion.
Chemistree Technology Inc. (CHMJF), closed Friday's trading session at $0.1377, off by 13.9375%, on 74,725 volume with 19 trades. The average volume for the last 3 months is 23,044 and the stock's 52-week low/high is $0.097000002/$0.605000019.
- Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Voices Support of SAFE Banking Act
- Chemistree Applauds Initial Success for Safe Banking Act in U.S.
- Chemistree Provides Washington State Update from Sugarleaf
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- B2Digital Inc. (BTDG) Announces Pinnacle Combat’s B2 Fighting Series Debut; Provides Business Update
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) CEO Rings Nasdaq Opening Bell
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) Announces Appointment of New Directors, Chairman to Corporate Board
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Opens the TSX Market
- Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Applauds Initial Success for Safe Banking Act in U.S.
- ChineseInvestors.com (CIIX) MicroCap Presentation Well Received, CBD Future Bright
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) to Acquire 19.9% Equity Interest of Coastal Green, a BC-Based Cannabis Retailer
- City View Green (CSE: CVGR) (OTCQB: LRZZF) Achieves Listing, Commences Trading on OTCQB Venture Market
- CloudCommerce (OTCQB: CLWD) Market-Behavior Tool Utilizes AI to Bolster Communication Campaigns
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Earth Science Tech, Inc. (ETST) Plans to Expand Reach of Distinctive 100% Natural CBD Oil
- Endonovo Therapeutics (OTCQB: ENDV) Receives Glowing Video Review on Revolutionary Medical Device
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Enters Strategic Agreement with Leading Chinese Infrared Camera Manufacturer
- Genprex, Inc. (NASDAQ: GNPX) Gene Therapies with Potential to Conquer Tough-to-Tackle Breast Cancers
- Geyser Brands Inc. (TSX.V: GYSR) Subsidiary Receives Natural Health Product Number from Health Canada
- Grapefruit Boulevard Investments Inc. (IGNG) 420 with CNW – Governor Cuomo Hints Cannabis Smoking Ban Could Be Included in Next Legalization Bill
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) Chief Marketing Officer Recognized on Forbes CMO Next List
- Green Hygienics Holdings Inc. (GRYN) 420 with CNW – The Benefits of Marijuana During Breast Cancer Treatment
- Hemptown USA - Advances Growth Strategy via Nutraceutical Manufacturing Facility Acquisition
- HTC Extraction Systems (TSX.V: HTC) 420 with CNW – Marijuana Banking Bill Changes Suggested to Win Republican Support
- INmune Bio, Inc. (NASDAQ: INMB) CEO Discusses Company Achievements in Interview; Director of Neuroscience to Present at World Immunotherapy Congress
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) Temporarily Suspends Production in California Amid Vape Product Safety Concerns
- Lexaria Bioscience Corp. (CSE: LXX)(OTC: LXRP) Powdered Formulation of CBD-Rich Hemp Oil Now Available to US Consumers
- Marijuana Company of America Inc. (MCOAD) 420 with CNW – Benefits of Marijuana to People with Traumatic Brain Injury
- MustGrow Biologics Corp (CSE: MGRO) 420 with CNW – Benefits of Marijuana to People with Traumatic Brain Injury
- Neutra Corp. (OTCQB: NTRR) Building Vertically to Establish Nutraceutical Revenues Through Hemp-Based CBD
- Nightfood, Inc. (OTCQB: NGTF) Products Spotted on Shelves in New Supermarket Chain
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) BTV Uncovers Companies in the Growing Cannabis Sector
- ORHub Inc. (ORHB) Settles Litigation with Former Chief Financial Officer
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Ongoing Drill Results Confirm Significant, Near Surface Cobalt and Nickel Mineralization
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Announces Recommencement of Production at Asphalt Ridge Facility
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Launches New Line of Best Selling Gummies in California
- Predictive Oncology Inc. (NASDAQ: POAI) Transforming Cancer-Treatment Outcomes via Proprietary Database
- Pressure BioSciences Inc. (PBIO) Patented PCT Platform Highlighted in 10 Separate
- Quest Patent Research Corp. (QPRC) Holds Broad Portfolio of Intellectual Property Assets
- Sharing Services Global Corporation (SHRG) Growing Global Network, Adds Thousands of Independent Representatives
- SinglePoint, Inc. (SING) Deploys Successful Pure Hemp Cigarette Marketing Strategy Ahead of NACS Event
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Receives $800,000 Purchase Order for its UR7 Rugged Clamshell Handset
- Spectrum Global Solutions, Inc. (SGSI) Cuts More Than $800 Thousand in Convertible Debt
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) Announces Expansion With New Manufacturing Facility
- SRAX Inc. (NASDAQ: SRAX) to Present at the 5th Annual B. Riley Consumer and Media Conference in NYC
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) CEO to Participate at September 17 Battery Next Summit in Boulder, CO
- Sugarmade, Inc. (SGMD) 420 with CNW – Medical Marijuana Prices in Michigan Rise as Recreational Sales Near
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) 420 with CNW – UK Experts Want Medical Marijuana Free for All
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) 420 with CNW – UK Experts Want Medical Marijuana Free for All
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) 420 with CNW – Mexican Senate to Start Debating Cannabis Legalization This Week
- TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) Completes SolDaze Acquisition
- Trxade Group Inc. (TRXD) Equipping Community Pharmacies with the Tools Needed to Overcome Their Biggest Challenges
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) Announces Partnership with Linneo Health to Supply Medical Cannabis in Europe
- VPR Brands, LP (VPRB) to Debut Premier GOLDLINE CBD Products at NACS 2019
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Developing Robust Retail Network for CBD Products
- Willow Biosciences Inc. (CSE: WLLW) 420 with CNW – Massachusetts Lawmakers Move to Address Vaping Dangers
- Xalles Holdings Inc. (XALL) Discusses its Blockchain Technology in Exclusive Audio Interview
- Youngevity International, Inc. (NASDAQ: YGYI) Announces Closing of Public Offering of Series D Cumulative Redeemable Perpetual Preferred Stock Offering
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.